Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
Yale University
ClinicalTrials.gov Identifier:
NCT00576121
First received: December 15, 2007
Last updated: June 22, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)